drugset / Trial / NCT06310200

Sphenopalatine Ganglion Block and Cold Induced Headaches

NCT06310200

Phase 1 Active not recruiting 30 enrolled Wright State University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The primary objective of this study is to determine if a sphenopalatine ganglion (SPG) block, performed through intranasal atomization of 4% lidocaine, is able to prevent cold induced cephalgia ("Brain Freeze"). Secondary objectives will be to determine the degree of decreased pain/duration of brain freeze after sphenopalatine ganglion block

Timeline

Start
2025-01-01
Primary completion
2025-05-01
Completion
2025-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1 ml Intranasal

Indications